|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 63/00 | |
| C07J 71/00 | |||
| A61P 29/00 | |||
| A61K 31/58 | |||
| A61K 31/585 | |||
| A61K 31/56 |
| (11) | Number of the document | 3353190 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16781915.0 |
| Date of filing the European patent application | 2016-09-23 | |
| (97) | Date of publication of the European application | 2018-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/053545 |
| Date | 2016-09-23 |
| (87) | Number | WO 2017/053868 |
| Date | 2017-03-30 |
| (30) | Number | Date | Country code |
| 201562222632 P | 2015-09-23 | US |
| (72) |
VISNICK, Melean, US
JIANG, Xin, US
HOTEMA, Martha, R., US
LEE, Chitase, US
CAPRATHE, Bradley, William, US
ROARK, William, H., US
BOLTON, Gary, US
|
| (73) |
Reata Pharmaceuticals, Inc.,
2801 Gateway Drive, Suite 150, Irving, TX 75063-2648,
US
|
| (54) | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES |
| C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES |